FDA Clearance Tracker · P980022-S023
MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 17, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Jul 17, 2008
Approved
Time to decision
216 days
Received Dec 14, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980022-S023
- Device name
- MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEM
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Dec 14, 2007
- Decided
- Jul 17, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980022
Device type
- Device type
- Sensor, glucose, invasive (MDS)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN UPDATE OF SOFTWARE USED IN MODEL MMT 512 AND MMT 712 INSULIN PUMPS TO VERSION 2.2A.
Source documents
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.